US 11242339
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted A61KA61K31/517A61P
Quick answer
US patent 11242339 (Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria) held by United States Government as represented by the Department of Veterans Affairs expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/517, A61P, A61P21/00, A61P25/16